TAP2‐defective RMA‐S cells present Sendai virus antigen to cytotoxic T lymphocytes

Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy

1986 • 2,102 citations

Antigen Recognition by Class I-Restricted T Lymphocytes

1989 • 1,207 citations

Association of class I major histocompatibility heavy and light chains induced by viral peptides

1989 • 995 citations

Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.

1985 • 734 citations

TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4−8+ T cells

1992 • 726 citations

HLA-A2.1-Associated Peptides from a Mutant Cell Line: A Second Pathway of Antigen Presentation

1992 • 522 citations

HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides

1992 • 502 citations

Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex

1992 • 407 citations

Presentation of viral antigen controlled by a gene in the major histocompatibility complex

1990 • 381 citations

Cell Biology of Antigen Processing and Presentation to Major Histocompatibility Complex Class I Molecule-Restricted T Lymphocytes

1992 • 373 citations

Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter

1991 • 329 citations

Brefeldin A Specifically Inhibits Presentation of Protein Antigens to Cytotoxic T Lymphocytes

1989 • 329 citations

Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer

1992 • 322 citations

Gene organization and recombinational hotspots in the murine major histocompatibility complex

1986 • 312 citations

Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations

1975 • 312 citations

Ham-2 corrects the class I antigen-processing defect in RMA-S cells

1992 • 289 citations

Peptide selection by MHC class I molecules

1991 • 253 citations

Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation

1992 • 250 citations

On the nature of peptides involved in T cell alloreactivity.

1991 • 220 citations

Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis.

1991 • 215 citations

Defective Presentation of Endogenous Antigen by a Cell Line Expressing Class I Molecules

1990 • 202 citations

RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes.

1992 • 132 citations

Molecular analysis of H-2-deficient lymphoma lines. Distinct defects in biosynthesis and association of MHC class I heavy chains and beta 2-microglobulin observed in cells with increased sensitivity to NK cell lysis.

1989 • 115 citations

Major histocompatibility complex (MHC)-encoded HAM2 is necessary for antigenic peptide loading onto class I MHC molecules.

1992 • 111 citations

An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S.

1992 • 72 citations

Resistance to H-2-restricted but not to allo-H2-specific graft and cytotoxic T lymphocyte responses in lymphoma mutant.

1990 • 63 citations

In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides

1992 • 53 citations

New genes in the MHC that encode proteins for antigen processing

1992 • 49 citations

The RMA-S lymphoma mutant; consequences of a peptide loading defect on immunological recognition and graft rejection

1991 • 48 citations

Resistance to H-2-restricted but not to allo-H2-specific graft and cytotoxic T lymphocyte responses in lymphoma mutant.

1990 • 46 citations

In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up‐regulation of major histocompatibility complex class I molecules by short synthetic peptides

1992 • 30 citations

Cytotoxic T lymphocytes against the antigen‐processing‐defective RMA‐S tumor cell line

1992 • 24 citations